The abnormal function of RRAS2 is a triggering factor that perturbs downstream tumor signaling cascades (such as MEK-ERK signaling and the PI3K-mTOR pathway), promoting malignant transitions in various cancers (31,32). Here, RRAS2 is linked to cancer.